SAFETY PHARMACOLOGY SOCIETY (EIN 232766566) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2000

Legal Domicile

Principal Officer

KRYSTLE CORRELL

Phone

7035470874

Tax Period

2024-01-01 to 2024-12-31

SAFETY PHARMACOLOGY SOCIETY, founded in 2000, is a small nonprofit in the Health Care sector that reported $688K in total revenue in fiscal year 2018. Revenue grew 16% year-over-year, indicating healthy expansion.

Mission

TO PROMOTE THE AQUISITION AND UTILIZATION OF SCIENTIFIC INFORMATION; TO PROVIDE AN INTERACTIVE FORUM FOR THE ADVANCEMENT AND EXCHANGE OF INFORMATION AMONG ITS MEMBERS AND REPRESENTATIVES FROM INDUSTRY, ACADEMIA, AND GOVERNMENT.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $55,500

Program Service Revenue $476,376

Investment Income $25,125

Other Revenue $1,015

TOTAL REVENUE $558,016

Expense Breakdown

Grants Paid $4,600

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $497,828

Other Expenses $646,332

TOTAL EXPENSES $650,932

Year-over-Year Comparison

	2024	2023	Change
Revenue	$558,016	$504,661	+0.1%
Expenses	$650,932	$689,888	-0.1%
Net Income	$-92,916	$-185,227	-0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

140

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SIMON AUTHIER	PRESIDENT	1.00	Officer Director	$0	$0	$0
ANDREA GREITER-WILKE	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
ERIC ROSSMAN	VICE PRESIDENT-ELECT	1.00	Officer Director	$0	$0	$0
C MIKE FOLEY	TREASURER	1.00	Officer Director	$0	$0	$0
YEVGENIYA KOSHMAN	SECRETARY - ELECT	1.00	Officer Director	$0	$0	$0
DINAH MISNER	SECRETARY	1.00	Officer Director	$0	$0	$0
MARIE-LUCE BRODZINSKI-ROSSEELS	PAST PRESIDENT	1.00	Officer Director	$0	$0	$0
ALEXIS ASCAH	DIRECTOR	1.00	Director	$0	$0	$0
KHURAM CHAUDHARY	DIRECTOR	1.00	Director	$0	$0	$0
MARCI HARTER	DIRECTOR	1.00	Director	$0	$0	$0
JILL V NICHOLS	DIRECTOR	1.00	Director	$0	$0	$0
SRIDHARAN RAJAMANI	DIRECTOR	1.00	Director	$0	$0	$0
CHRISTOPHER P REGAN	DIRECTOR	1.00	Director	$0	$0	$0
YASUNARI KANDA	DIRECTOR	1.00	Director	$0	$0	$0
TESSA DE KORTE	DIRECTOR	1.00	Director	$0	$0	$0
KRYSTLE CORRELL	EXECUTIVE DIRECTOR	15.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$558,016	$650,932	$757,977	$-92,916
2023	$504,661	$689,888	$800,406	$-185,227
2022	$584,000	$607,144	$910,542	$-23,144
2021	$393,965	$344,570	$1,046,750	$49,395
2020	$352,499	$455,570	$950,524	$-103,071
2019	$640,650	$743,986	$1,046,183	$-103,336
2018	$687,870	$676,364	$1,082,415	$11,506

SAFETY PHARMACOLOGY SOCIETY